18F-FTP shows absent-to-low binding to tau aggregates in non-AD tauopathies (e.g., chronic traumatic encephalopathy or tau subtypes of FTLD) (162,187,188), but tau PET should not be used clinically to rule in these conditions. The gene discussed is MAPT; the disease is Alzheimer disease.